Given that the company put the emphasis on the delay of mining license on DRC, I don't believe DRC was waiting on evidence of funding else they would have communicated that to AVZ
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%